Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC
Clinical trial NCT03672305 · UNKNOWN
Trial details
- NCT number
- NCT03672305
- Sponsor
- The Second Hospital of Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2019-10-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.